oxotremorine has been researched along with (pPNET) Peripheral Primitive Neuroectodermal Tumors in 2 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palmer, RK | 1 |
| Yule, DI | 1 |
| McEwen, EL | 2 |
| Williams, JA | 1 |
| Fisher, SK | 2 |
| Lovell, SC | 1 |
| Landon, RE | 1 |
2 other studies available for oxotremorine and (pPNET) Peripheral Primitive Neuroectodermal Tumors
| Article | Year |
|---|---|
Agonist-specific calcium signaling and phosphoinositide hydrolysis in human SK-N-MCIXC neuroepithelioma cells.
Topics: Adenosine Triphosphate; Calcium; Endothelins; Humans; Hydrolysis; Neuroectodermal Tumors, Primitive, | 1994 |
Cyclic AMP potentiates receptor-stimulated phosphoinositide hydrolysis in human neuroepithelioma cells.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Cyclic AMP; Drug Synergism; Endothelins; Humans; H | 1992 |